Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Patoia

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in ItalyF Roila, E Ballatori, L Patoia, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing dosesA Del Favero, L Patoia, R Rosina, et al.
British Journal of Rheumatology|April 1, 1996
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteersL Patoia, L Santucci, P Furno, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of parenteral diclofenac sodium on upper gastrointestinal motility after food in manG Bassotti, G Bucaneve, C Betti, et al.
American Journal of Clinical Oncology|June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind studyF Roila, E Boschetti, M Tonato, et al.
Stroke|May 1, 1987
Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction: a case-control studyS Ricci, L Patoia, M Berrettini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 1999
Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapyL Patoia, A Del Favero, A Giglietti, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open studyS Pauluzzi, A Del Favero, F Menichetti, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in ItalyF Roila, E Ballatori, L Patoia, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing dosesA Del Favero, L Patoia, R Rosina, et al.
British Journal of Rheumatology|April 1, 1996
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteersL Patoia, L Santucci, P Furno, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of parenteral diclofenac sodium on upper gastrointestinal motility after food in manG Bassotti, G Bucaneve, C Betti, et al.
American Journal of Clinical Oncology|June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind studyF Roila, E Boschetti, M Tonato, et al.
Stroke|May 1, 1987
Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction: a case-control studyS Ricci, L Patoia, M Berrettini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 1999
Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapyL Patoia, A Del Favero, A Giglietti, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open studyS Pauluzzi, A Del Favero, F Menichetti, et al.
Pageof 2